m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00456)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
ZNF750
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Methyltransferase-like 3 (METTL3) [WRITER]
Representative RNA-seq result indicating the expression of this target gene regulated by METTL3 | ||
Cell Line | Liver | Mus musculus |
Treatment: Mettl3-deficient liver
Control: Wild type liver cells
|
GSE197800 | |
Regulation |
|
logFC: 1.24E+00 p-value: 8.99E-10 |
More Results | Click to View More RNA-seq Results | |
Representative RIP-seq result supporting the interaction between ZNF750 and the regulator | ||
Cell Line | MDA-MB-231 | Homo sapiens |
Regulation | logFC: 5.92E+00 | GSE60213 |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | m6A modifications maintained the low expression level of ZNF750 in NPC. Knocking down METTL3 stimulated endogenous Zinc finger protein 750 (ZNF750) expression, and vice versa. | |||
Target Regulation | Down regulation | |||
Responsed Disease | Nasopharyngeal carcinoma | ICD-11: 2B6B | ||
Cell Process | Cell apoptosis | |||
In-vitro Model | 5-8F | Nasopharyngeal carcinoma | Homo sapiens | CVCL_C528 |
6-10B | Nasopharyngeal carcinoma | Homo sapiens | CVCL_C529 | |
C666-1 | Nasopharyngeal carcinoma | Homo sapiens | CVCL_7949 | |
HNE-1 | Nasopharyngeal carcinoma | Homo sapiens | CVCL_0308 | |
HONE-1 | Nasopharyngeal carcinoma | Homo sapiens | CVCL_8706 | |
NP69 (A human immortalized nasopharyngeal epithelial) | ||||
S18 | Nasopharyngeal carcinoma | Homo sapiens | CVCL_B0U9 | |
S26 | Nasopharyngeal carcinoma | Homo sapiens | CVCL_B0UB | |
SUNE1 | Nasopharyngeal carcinoma | Homo sapiens | CVCL_6946 | |
In-vivo Model | BALB/c-nu mice (4-6 weeks old, female) were purchased from Charles River Laboratories (Beijing, China), and SUNE1-vector-luciferase or SUNE1-ZNF750-luciferase cells (1 × 106) were subcutaneously injected into the dorsal or ventral flank. | |||
Nasopharyngeal carcinoma [ICD-11: 2B6B]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | m6A modifications maintained the low expression level of ZNF750 in NPC. Knocking down METTL3 stimulated endogenous Zinc finger protein 750 (ZNF750) expression, and vice versa. | |||
Responsed Disease | Nasopharyngeal carcinoma [ICD-11: 2B6B] | |||
Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
Target Regulation | Down regulation | |||
Cell Process | Cell apoptosis | |||
In-vitro Model | 5-8F | Nasopharyngeal carcinoma | Homo sapiens | CVCL_C528 |
6-10B | Nasopharyngeal carcinoma | Homo sapiens | CVCL_C529 | |
C666-1 | Nasopharyngeal carcinoma | Homo sapiens | CVCL_7949 | |
HNE-1 | Nasopharyngeal carcinoma | Homo sapiens | CVCL_0308 | |
HONE-1 | Nasopharyngeal carcinoma | Homo sapiens | CVCL_8706 | |
NP69 (A human immortalized nasopharyngeal epithelial) | ||||
S18 | Nasopharyngeal carcinoma | Homo sapiens | CVCL_B0U9 | |
S26 | Nasopharyngeal carcinoma | Homo sapiens | CVCL_B0UB | |
SUNE1 | Nasopharyngeal carcinoma | Homo sapiens | CVCL_6946 | |
In-vivo Model | BALB/c-nu mice (4-6 weeks old, female) were purchased from Charles River Laboratories (Beijing, China), and SUNE1-vector-luciferase or SUNE1-ZNF750-luciferase cells (1 × 106) were subcutaneously injected into the dorsal or ventral flank. | |||